Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-27
DOI
10.1038/s41388-020-1166-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Tumor Cells: Diagnostic and Therapeutic Applications
- (2018) Eric Lin et al. Annual Review of Biomedical Engineering
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
- (2017) Xin Zhang et al. Molecular Cancer
- SWI/SNF complex in cancer
- (2017) Chao Lu et al. NATURE GENETICS
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
- (2016) Yang Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy
- (2015) Chuanli Ren et al. INTERNATIONAL JOURNAL OF CANCER
- The ZNF304-integrin axis protects against anoikis in cancer
- (2015) Burcu Aslan et al. Nature Communications
- CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
- (2014) Sadhna R. Vora et al. CANCER CELL
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
- (2014) Brigitte Rack et al. JNCI-Journal of the National Cancer Institute
- ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
- (2014) Meenu Jain et al. PLoS One
- MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
- (2013) S.-J. Yu et al. CLINICAL CANCER RESEARCH
- Defining the Protein–Protein Interaction Network of the Human Hippo Pathway
- (2013) Wenqi Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
- (2013) Fernando Calvo et al. NATURE CELL BIOLOGY
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
- (2012) Dahu Chen et al. NATURE MEDICINE
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
- (2012) J. M. Lamar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNM-Klassifikation beim Mammakarzinom
- (2010) H.-P. Sinn et al. PATHOLOGE
- Expression and Cytoplasmic Localization of SAM68 Is a Significant and Independent Prognostic Marker for Renal Cell Carcinoma
- (2009) Z. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started